About
Science you can stand behind. Support patients can follow.
RESSETT LAB is the clinical practice of Dr. Aminata Kanu, trading through Eve's Ease Ltd.
Founder
Dr. Aminata Kanu
Protein biochemist · GLP-1 specialist · Author of The GLP-1 Graduate
Dr. Kanu is a protein biochemist with a PhD from the University of Bath. She spent over a decade in industrial science at AstraZeneca and Unilever, and has also worked as an independent consultant in maternal and global health systems across West Africa, including Sierra Leone and Senegal.
She is a Level 4 Strength and Conditioning Coach and a HYROX Performance Coach, and she has taken tirzepatide herself. That combination of laboratory science, practical coaching and lived experience is the foundation of RESSETT LAB: explaining what GLP-1 medicines do in the body, then turning it into nutrition and training that real patients can sustain.
She is the author of The GLP-1 Graduate: A Scientist's Guide to the Ozempic Exit, available on Amazon.
- PhD, Protein Biochemistry · University of Bath
- AstraZeneca · Senior Scientist
- Unilever · Worldwide patent
- Level 4 Strength and Conditioning Coach · HYROX Performance Coach
- Author · The GLP-1 Graduate

Our standard
Mechanism first
We explain why something works before we recommend it, so your team can answer patient questions with confidence.
Our standard
Qualified claims
We say what the evidence supports and no more. Our content is written to stand up to clinical review.
Our standard
Your brand, not ours
Our resources carry your clinic's name. Patients build loyalty to your service.
Contact
Let's talk about your clinic
The quickest way to start is a 30-minute discovery call. Clinics, coaches, brands and media are all welcome to email.
Take the clinic diagnostic firstBook a discovery call
Choose a time that suits you. We will cover your service, your patients and the right next step.
Choose a timeCoach, brand, media or other enquiry? Book an enquiry call.
Eve's Ease Ltd, trading as RESSETT LAB. 86-90 Paul Street, London EC2A 4NE.